|
Research: Biofrontera June 06, 2006  New issue Biofrontera plans to be listed on the main German stock market. The company is a specialist biotechnology group focused on the development of dermatological treatments. Strong product pipeline. Biofrontera has one product in phase two b/three clinical trials and... ...Subscribe to VISCARDI Research... |
